Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

RPG LIFE SCIENCES 2023-24 Annual Report Analysis
Thu, 27 Jun

RPG LIFE SCIENCES has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

RPG LIFE SCIENCES Income Statement Analysis

  • Operating income during the year rose 13.5% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 24.7% YoY during the fiscal. Operating profit margins witnessed a fall and down at 22.2% in FY24 as against 20.2% in FY23.
  • Depreciation charges increased by 10.1% and finance costs increased by 25.2% YoY, respectively.
  • Other income grew by 50.2% YoY.
  • Net profit for the year grew by 29.6% YoY.
  • Net profit margins during the year grew from 13.2% in FY23 to 15.1% in FY24.

RPG LIFE SCIENCES Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 5,128 5,821 13.5%
Other income Rs m 48 72 50.2%
Total Revenues Rs m 5,176 5,893 13.8%
Gross profit Rs m 1,035 1,291 24.7%
Depreciation Rs m 155 171 10.1%
Interest Rs m 12 14 25.2%
Profit before tax Rs m 917 1,178 28.5%
Tax Rs m 240 302 25.5%
Profit after tax Rs m 676 877 29.6%
Gross profit margin % 20.2 22.2
Effective tax rate % 26.2 25.6
Net profit margin % 13.2 15.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Must See: These Segments are Witnessing Incredible Growth with Modi's Push

RPG LIFE SCIENCES Balance Sheet Analysis

  • The company's current liabilities during FY24 stood at Rs 1 billion as compared to Rs 1 billion in FY23, thereby witnessing an increase of 27.4%.
  • Current assets rose 13% and stood at Rs 3 billion, while fixed assets rose 38% and stood at Rs 2 billion in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 5 billion as against Rs 4 billion during FY23, thereby witnessing a growth of 22%.

RPG LIFE SCIENCES Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 3,076 3,749 21.9
 
Current Liabilities Rs m 1,028 1,310 27.4
Long-term Debt Rs m 0 0 0.0
Total Liabilities Rs m 4,194 5,123 22.2
 
Current assets Rs m 2,641 2,981 12.9
Fixed Assets Rs m 1,553 2,142 37.9
Total Assets Rs m 4,194 5,123 22.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



RPG LIFE SCIENCES Cash Flow Statement Analysis

  • RPG LIFE SCIENCES's cash flow from operating activities (CFO) during FY24 stood at Rs 944 million, an improvement of 3.9% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs -792 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs -203 million on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs -51 million from the Rs -321 million net cash flows seen during FY23.

RPG LIFE SCIENCES Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m 908 944 3.9%
Cash Flow from Investing Activities Rs m -1,058 -792 -
Cash Flow from Financing Activities Rs m -171 -203 -
Net Cash Flow Rs m -321 -51 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for RPG LIFE SCIENCES

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 53.0, an improvement from the EPS of Rs 40.9 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 1,650.0, stands at 31.1 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 7.3 times, while the price to sales ratio stands at 4.7 times.
  • The company's price to cash flow (P/CF) ratio stood at 19.3 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 310.0 351.9
TTM Earnings per share Rs 40.9 53.0
Diluted earnings per share Rs 40.9 53.0
Price to Cash Flow x 13.8 19.3
TTM P/E ratio x 17.0 31.1
Price / Book Value ratio x 3.9 5.4
Market Cap Rs m 12,109 20,176
Dividends per share (Unadj.) Rs 12.0 16.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for RPG LIFE SCIENCES

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 2.3x during FY24, from 2.6x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 82.8x during FY24, from 80.7x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 23.4% during FY24, from 22.0% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 31.8% during FY24, from 30.2% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 17.4% during FY24, from 16.4% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 2.6 2.3
Debtors’ Days Days 266 308
Interest coverage x 80.7 82.8
Debt to equity ratio x 0.0 0.0
Return on assets % 16.4 17.4
Return on equity % 22.0 23.4
Return on capital employed % 30.2 31.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how RPG LIFE SCIENCES has performed over the last 5 years, please visit here.

RPG LIFE SCIENCES Share Price Performance

Over the last one year, RPG LIFE SCIENCES share price has moved up from Rs 902.9 to Rs 1,650.0, registering a gain of Rs 747.1 or around 82.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 36,790.1 (up 0.3%). Over the last one year it has moved up from 25,406.2 to 36,790.1, a gain of 11,384 points (up 44.8%).

Overall, the S&P BSE SENSEX is up 24.8% over the year.

(To know more, check out historical annual results for RPG LIFE SCIENCES and quarterly results for RPG LIFE SCIENCES)

Annual Report FAQs

What is the current share price of RPG LIFE SCIENCES?

RPG LIFE SCIENCES currently trades at Rs 1,986.1 per share. You can check out the latest share price performance of RPG LIFE SCIENCES here...

What was the revenue of RPG LIFE SCIENCES in FY24? How does it compare to earlier years?

The revenues of RPG LIFE SCIENCES stood at Rs 5,893 m in FY24, which was up 13.8% compared to Rs 5,176 m reported in FY23.

RPG LIFE SCIENCES' revenue has grown from Rs 3,766 m in FY20 to Rs 5,893 m in FY24.

Over the past 5 years, the revenue of RPG LIFE SCIENCES has grown at a CAGR of 11.8%.

What was the net profit of RPG LIFE SCIENCES in FY24? How does it compare to earlier years?

The net profit of RPG LIFE SCIENCES stood at Rs 877 m in FY24, which was up 29.6% compared to Rs 676 m reported in FY23.

This compares to a net profit of Rs 515 m in FY22 and a net profit of Rs 400 m in FY21.

Over the past 5 years, RPG LIFE SCIENCES net profit has grown at a CAGR of 31.8%.

What does the cash flow statement of RPG LIFE SCIENCES reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of RPG LIFE SCIENCES reveals:

  • Cash flow from operations increased in FY24 and stood at Rs 944 m as compared to Rs 908 m in FY23.
  • Cash flow from investments increased in FY24 and stood at Rs -792 m as compared to Rs -1,058 m in FY23.
  • Cash flow from financial activity decreased in FY24 and stood at Rs -203 m as compared to Rs -171 m in FY23.

Here's the cash flow statement of RPG LIFE SCIENCES for the past 5 years.

(Rs m)FY20FY21FY22FY23FY24
From Operations502583648908944
From Investments-107-80-347-1,058-792
From Financial Activity-393-105-135-171-203
Net Cashflow2398166-321-51

What does the Key Ratio analysis of RPG LIFE SCIENCES reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of RPG LIFE SCIENCES reveals:

  • Operating profit margins witnessed a fall and down at 22.2% in FY24 as against 20.2% in FY23.
  • Net profit margins grew from 13.2% in FY23 to 15.1% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.0 as compared to 0.0 in FY23.

Here's the ratio/financial analysis of RPG LIFE SCIENCES for the past 5 years.

 FY20FY21FY22FY23FY24
Operating Profit Margin (%)14.518.219.820.222.2
Net Profit Margin (%)7.710.311.713.215.1
Debt to Equity Ratio (x)0.00.00.00.00.0

 

Equitymaster requests your view! Post a comment on "RPG LIFE SCIENCES 2023-24 Annual Report Analysis". Click here!